Nearly five million Americans have a little-known sleep disorder, hypersomnia, that leaves them feeling exhausted even after getting eight hours of rest a night. “Sleep is the VIP service ...

The Plymouth Meeting, Pa., company termed the FDA's refusal to file a short-term setback and said its long-term strategy for pitolisant in idiopathic hypersomnia is on track with its focus on a ...

With idiopathic hypersomnia, it’s hard to get to a diagnosis, much less an effective treatment. Learn what you need to know to take control of your care.

Idiopathic Hypersomnia (IH) is a rare and chronic neurological disease that is characterized by excessive daytime sleepiness (EDS) despite sufficient or even long sleep time. EDS in IH cannot be ...

These quiz questions about idiopathic hypersomnia (IH) are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those of your physician colleagues.

Harmony (JO:HARJ)'s management, during a meeting on January 13, conveyed optimism for WAKIX's future, particularly its expected label expansion in 2025 to treat idiopathic hypersomnia (IH).

Searching for effective treatment options for 'Hypersomnia symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

LUMRYZ™ generated $50.4 million in sales in the fourth quarter, up 158% year-over-year, taking the full-year total to $169.1 million, in line ...

in adult patients with idiopathic hypersomnia (IH). Harmony’s 2025 net revenue guidance of $820-$860 million remains unchanged. “We are disappointed with this short-term setback, but our long ...